日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

LAM-003, a new drug for treatment of tyrosine kinase inhibitor-resistant FLT3-ITD-positive AML

LAM-003 是一种用于治疗酪氨酸激酶抑制剂耐药的 FLT3-ITD 阳性急性髓系白血病的新药。

Beeharry, Neil; Landrette, Sean; Gayle, Sophia; Hernandez, Marylens; Grotzke, Jeff E; Young, Peter R; Beckett, Paul; Zhang, Xuan; Carter, Bing Z; Andreeff, Michael; Halene, Stephanie; Xu, Tian; Rothberg, Jonathan; Lichenstein, Henri

Network modeling of kinase inhibitor polypharmacology reveals pathways targeted in chemical screens

激酶抑制剂多药理学的网络建模揭示了化学筛选的目标通路

Ursu, Oana; Gosline, Sara J C; Beeharry, Neil; Fink, Lauren; Bhattacharjee, Vikram; Huang, Shao-Shan Carol; Zhou, Yan; Yen, Tim; Fraenkel, Ernest

Pixantrone induces cell death through mitotic perturbations and subsequent aberrant cell divisions

吡沙酮通过干扰有丝分裂和随后的异常细胞分裂诱导细胞死亡。

Beeharry, Neil; Di Rora, Andrea Ghelli Luserna; Smith, Mitchell R; Yen, Timothy J

HuR posttranscriptionally regulates WEE1: implications for the DNA damage response in pancreatic cancer cells.

HuR 转录后调控 WEE1:对胰腺癌细胞 DNA 损伤反应的意义

Lal Shruti, Burkhart Richard A, Beeharry Neil, Bhattacharjee Vikram, Londin Eric R, Cozzitorto Joseph A, Romeo Carmella, Jimbo Masaya, Norris Zoë A, Yeo Charles J, Sawicki Janet A, Winter Jordan M, Rigoutsos Isidore, Yen Timothy J, Brody Jonathan R

Oncogenic RAS regulates BRIP1 expression to induce dissociation of BRCA1 from chromatin, inhibit DNA repair, and promote senescence

致癌RAS调控BRIP1表达,诱导BRCA1从染色质上解离,抑制DNA修复,并促进细胞衰老。

Tu, Zhigang; Aird, Katherine M; Bitler, Benjamin G; Nicodemus, Jasmine P; Beeharry, Neil; Xia, Bing; Yen, Tim J; Zhang, Rugang

Doxorubicin resistance in a novel in vitro model of human pleomorphic liposarcoma associated with alternative lengthening of telomeres

在一种新型的人类多形性脂肪肉瘤体外模型中,多柔比星耐药性与端粒的替代性延长有关

Mitchell, Marcy A; Johnson, Jay E; Pascarelli, Kara; Beeharry, Neil; Chiourea, Maria; Gagos, Sarantis; Lev, Dina; von Mehren, Margaret; Kipling, David; Broccoli, Dominique